AACAP+CACAP Joint Annual Meeting
Program Schedule
Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.


New Research Poster 3 (open)
New Research Poster Session 3

Thursday, October 20, 2011: 1:00 PM-3:30 PM
 
3.1
Conduct Disorder and Initiation of Alcohol, Marijuana, and Cocaine
Christian Jean Hopfer, M.D. University of Colorado Denver School of Medicine, Aurora, CO
Stacy Salomonsen-Sautel, Ph.D. University of Colorado School of Medicine, Aurora, CO
Min Sung-Joon, Ph.D. University of Colorado School of Medicine, Aurora USA
Susan Mikulich-Gilbertson, Ph.D. University of Colorado School of Medicine, Aurora USA
Matt McQueen, Ph.D. University of Colorado Boulder, Boulder, CO
Thomas Crowley, M.D. University of Colorado School of Medicine, Aurora, CO
Susan E. Young, Ph.D. University of Colorado School of Medicine, Aurora, CO
Robin Corley, Ph.D. University of Colorado Boulder, Boulder, CO
Joseph Sakai, M.D. University of Colorado School of Medicine, Aurora USA
Analice Hoffenberg, M.D. University of Colorado School of Medicine, Aurora, CO
Christian Thurstone, M.D. Denver Health and Hospital Authority, Denver, CO
Christie Hartman, Ph.D. University of Colorado School of Medicine, Aurora USA
Michael Stallings, Ph.D. University of Colorado Boulder, Boulder, CO
John Hewitt, Ph.D. University of Colorado Boulder, Boulder, CO
 
3.2
Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders in Children and Adolescents: A Placebo-Controlled, Randomized, Double-Blind Clinical Trial
Christian Fleischhaker, M.D. University Clinic Freiburg, Freiburg Germany
Klaus Hennighausen, M.D. University Clinic Freiburg, Freiburg Germany
Katja Schneider-Momm, M.D. University Clinic Freiburg, Freiburg Germany
Eberhard Schulz, M.D. University Hospital Freiburg, Freiburg Germany
 
3.3
Genetic and Environmental Influences on Childhood Psychopathic Traits
Lu Dong, M.H.S. Emory University, Atlanta, GA
Courtney Ficks, M.A. Emory University, Atlanta, GA
Irwin D. Waldman, Ph.D. Emory University, Atlanta, GA
 
3.4
Callous Unemotional Traits in Untreated Adolescent Conduct Disorder: Differences in Inhibition and Reward Choice Performance
Charles W. Mathias, M.S., Ph.D. The University of Texas Health Science Center at San Antonio, San Antonio, TX
Donald M. Dougherty, Ph.D. The University of Texas Health Science Center at San Antonio, San Antonio, TX
W. Burleson Daviss, M.D. Dartmouth Medical School, Lebanon, NH
Michael Anthony Dawes, M.D. University of Texas Health Science Center at San Antonio, San Antonio, TX
Rene Luis Olvera, M.D., M.P.H. University of Texas Health Science Center at San Antonio, San Antonio, TX
Arielle H. Sheftall, Ph.D. The University of Texas Health Science Center at San Antonio, San Antonio, TX
Amanda J. Lopez, B.A. The University of Texas Health Science Center at San Antonio, San Antonio, TX
 
3.5
A Multi-State Study on Mental Health Evaluations for Children in Foster Care
Munya Hayek, M.D. Tufts Medical Center, Boston, MA
Thomas I. Mackie, M.A., M.P.H. Brandeis University, Waltham, MA
Angie Mae Rodday, M.S. Tufts Medical Center, Boston, MA
Emily Dawson, B.A. Tufts Medical Center, Boston, MA
Christopher Bellonci, M.D. Tufts Medical Center, Boston, MA
John Sargent, M.D. Tufts Medical Center, Boston, MA
Laurel K. Leslie, M.D., M.P.H. Tufts Medical Center, Boston, MA
 
3.6
Psychological, Nutritional, and Humoral Factors Involved in Pediatric Obesity
Allison S. Larr, B.A. Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY
Melissa M. Benedict, M.A. Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY
Hussam U. Haq, M.D. Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY
Alexis L. Moreno, M.S.W. Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY
Laura J. Panek, R.N. Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY
Lawrence A. Maayan, M.D. Nathan S. Kline Institute, NYU Child Study Center, Yonkers, NY
 
3.7
The Patterns of Sleep Disorders and Circadian Rhythm Disruptions in Children and Adolescents with Fetal Alcohol Spectrum Disorders
Shery Goril, B.S., M.S. Youthdale Child and Adolescent Sleep Centre, Toronto, ON
Colin M. Shapiro, FRCPC, M.B.B.S., Ph.D. Youthdale Child and Adolescent Sleep Clinic, University of Toronto, Toronto, ON
 
3.8
Latent Personality Profiles and the Relations with Psychopathology and Psychopathic Traits in Detained Adolescents
Mieke Decuyper, Ph.D. Ghent University, Ghent Belgium
Barbara De Clercq, Ph.D. Ghent University, Ghent Belgium
Olivier Colins, Ph.D. Curium-Leiden University Medical Center, AA Leiden Netherlands
Patricia Bijttebier, Ph.D. University of Leuven, Leuven Belgium
Annelore Roose University of Leuven, Leuven Belgium
Robert Vermeiren, M.D. Leiden University, Oegstgeest Netherlands
Filip De Fruyt, Ph.D. Ghent University, Ghent Belgium
 
3.9
Sexual Education and STI/HIV Prevention Websites for Teens
Laura Whiteley, M.D. Brown University, Providence, RI
Justin Mello, B.A. Lifespan, Brown University, Providence, RI
Larry K. Brown, M.D. Brown University School of Medicine; RI Hospital, Providence, RI
Evan Hancock, B.A. Lifespan, Brown University, Providence, PR
 
3.10
Maternal Rejection, Family, and Cognitive Factors: Modeling Aggression in Children with ADHD
Elif Ercan, Ph.D. Ege University, Izmir Turkey
Eyüp Sabri Ercan, M.D. Ege University, Izmir Turkey
Burge Kabukcu Basay, M.D. Ege University, Izmir Turkey
Taciser Uysal, M.D. Ege University, Izmir Turkey
Cahide Aydin, M.D. Ege University, Izmir Turkey
 
3.11
A Multi-Informant, Multi-Study Examination of Aggression Type and Depression in Preschool, Middle Childhood, and Adolescence
Jennifer Hepditch, B.A., B.S. University of Ottawa, Ottawa, ON
Tracy Vaillancourt, Ph.D. University of Ottawa, Ottawa, ON
 
3.12
Predicting Partners' Physical Aggression: Childhood Experiences of Adversity and the Moderating Role of Narrative Coherence
Elizabeth R. Weber, M.A. Judge Baker Children's Center, Boston, MA
Cynthia R. Davis, D.Phil. Judge Baker Children's Center, Boston, MA
Eric Dearing, D. Phil. Boston College, Boston, MA
Judith Ann Crowell, M.D. Stony Brook University, Stony Brook, NY
 
3.13
Mental Health Follow-up Among Young People Making Their First-Ever Emergency Department Presentation for Self-Harm
Jennifer Bethell, M.S.C. University of Toronto, Toronto, ON
Anne E. Rhodes, Ph.D. University of Toronto, Toronto, ON
Sue Bondy, Ph.D. University of Toronto, Toronto, ON
Wendy Lou, Ph.D. University of Toronto, Toronto, ON
Astrid Guttmann, M.D., M.S.C. University of Toronto, Toronto, ON
 
3.14
Estimation of the Prevalence of Oppositional Defiant Disorder Among a School-Age Sample: Differences According to Source and Sex
Esther Cardo, Ph.D. Neuropediatric Hospital Son Llatzer, University of Balearic Island, Palma de Mallorca Spain
Vicky Mesiel, M.D. Universtity of Ballearic Island, Palma de Mallorca Spain
Mateu Servera, Ph.D. University of Balearic Island, Palma de Mallorca Spain
Gloria Garcia-Banda, Ph.D. Universtity of Ballearic Island, Palma de Mallorca Spain
Begoña De Azua, Dr.P.H. Hosptial Son Llatzer, Palma de Mallorca Spain
Carmen Vidal, Dr.P.H. Hosptial Son Llatzer, Palma de Mallorca Spain
Guillermo Larraz, M.D. Universtity of Ballearic Island, Palma de Mallorca Spain
Natalia Perez-Jaume, M.D. Hospital Son Llatzer, Palma de Mallorca Spain
 
3.15
Comparison of DSM-IV and Proposed DSM-5 Substance Use Disorder Criteria in U.S. Adolescents
Brady G. Case, M.D. Bradley Hospital, East Providence, RI
Jianping He, M.S. National Institute of Mental Health, Bethesda, MD
Kathleen R. Merikangas, Ph.D. National Institute of Mental Health, Bethesda, MD
 
3.16
Non-Suicidal Self Injurious Behavior Among Adolescents in Turkey and Northern Cyprus
Ayse Zeki V, M.D. Hacettepe University Faculty of Medicine, Ankara Turkey
Fusun Cuhadaroglu Cetin, M.D. Hacettepe University School of Medicine, Ankara Turkey
 
3.17
A 2-Year Prospective Study of DSM-IV Axis I Disorders in Children with Recent Onset Epilepsy
Jana E. Jones, Ph.D. University of Wisconsin School of Medicine and Public Health, Madison, WI
Daren Jackson, Ph.D. University of Wisconsin School of Medicine and Public Health, Madison, WI
Alanna Kessler, Psy.D. University of Wisconsin School of Medicine and Public Health, Madison, WI
Rochelle Caplan, M.D. Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles, Los Angeles, CA
Bruce Hermann, Ph.D. University of Wisconsin School of Medicine and Public Health, Madison, WI
 
3.18
Comparing Primary School Children Mental Health and Risk Factors Across Europe
Viviane Kovess-Masfety, M.D., Ph.D. Ecole des Hautes Etudes en Sante Publique School of Public Health , Paris Descartes University, Paris France
Ondine Pez, Ph.D. SCMHE Study Coordinator, Paris France
Anders C. Boyd, Ph.D. Inserm Unité Mixte de Recherche en Santé 707, EHESP, Paris France
Josep M. Haro, M.D., M.P.H., Ph.D. Parc Sanitari Sant Joan de Déu, Barcelona Spain
Dietmar Golitz, Ph.D. Leuphana University of Lüneburg, Lüneburg Germany
Rowella Kuijpers, Ph.D. Candidate, M.S.C. Radboud University Nijmegen, Nijmegen Netherlands
Ceyda Eke, M.A. Yeniden Health and Education Society, Istanbul Turkey
Sigita Lesinskiene, M.D. Lithuanian Society of Child and Adolescent Psychiatry, Vilnius Lithuania
Zlatka Mihova, Ph.D. Foundation for Human Relations, Sophia Bulgaria
Mauro Carta, M.D. University of Cagliari, Cagliari Italy
Adina Bitfoi, M.D. The Romanian League for Mental Health, Bucharest Romania
 
3.19
Risk of Autism Spectrum Disorder in Low Birth Weight and Small for Gestational Age Infants
Katja Maria Lampi, M.S.C. University of Turku, Turku Finland
Liisa Lehtonen, M.D., Ph.D. University of Turku, Turku Finland
Phuong Lien Tran University of Turku, Turku Finland
Auli Partanen, M.S.C. University of Turku, Turku Finland
Venla Lehti, M.D. University of Turku, Turku Finland
P. Nina Banerjee, Ph.D. Columbia University, New York, NY
Mika Gissler, Ph.D. National Institute for Health and Welfare Fiji
Alan S. Brown, M.D., M.P.H. New York State Psychiatric Institute, New York, NY
Andre Sourander, M.D. University of Turku, Turku Finland
 
3.20
Childhood Pain As a Predictor of Antidepressant Medication Use: Findings From the Finnish Nationwide 1981 Birth Cohort Study
Terhi Luntamo, M.D. University of Turku, Turku Finland
Andre Sourander, M.D. University of Turku, Turku Finland
David Gyllenberg, M.D. University of Helsinki, Helsinki Finland
Minna Aromaa, Ph.D. Turku City Hospital, Turku Finland
 
3.21
Childhood and Adolescence Symptoms Predicting First Episode Psychosis in the General Population: The Northern Finland 1986 Birth Cohort
Pirjo H. Mäki, M.D., Ph.D. University of Oulu, Oulu University Hospital, Oulu Finland
Jouko Miettunen, Ph.D. University of Oulu, Oulu Finland
Irma Moilanen, M.D., Ph.D. University of Oulu, Oulu Finland
Marika Kaakinen, M.S.C. University of Oulu, Oulu Finland
Anja Taanila, Ph.D. University of Oulu, Oulu Finland
Graham Murray, M.D., Ph.D. University of Cambridge, Cambridge United Kingdom
Tuula Hurtig, Ph.D. University of Oulu, Oulu Finland
Matti Joukamaa, M.D., Ph.D. University of Tampere, Tampere Finland
Markus Heinimaa, M.D., Ph.D. University of Turku, Turku Finland
Sebastian Therman, M.A. National Institute for Health and Welfare, Helsinki Finland
Juha M. Veijola, M.D., Ph.D. University of Oulu, Oulu University Hospital, Oulu Finland
 
3.22
Changes in Young Men's Mental Health: A 10-Year Time Trend Study of Finnish 18-Year-Old Men
Petteri Multimaeki, M.D. University of Turku, Turku Finland
Andre Sourander, M.D. University of Turku, Turku Finland
Kai Parkkola, M.D., Ph.D. Navy Command Finland, Turku Finland
 
3.23
Resilience and Risk for Psychopathology in Adolescence
Anna E. Ordóñez, M.D. University of California, San Francisco, San Francisco, CA
Ximena Pineda, M.S. Universided de Iberoamerica, Escazu Costa Rica
Gabriela Ivankovich, M.D. Universided de Iberoamerica Costa Rica
Kevin Delucchi, Ph.D. University of California, San Francisco, San Francisco, CA
Luis D. Herrera, M.D., M.P.H. PSIQUE, Escazu Costa Rica
Carol A. Mathews, M.D. University of California, San Francisco, Langley Porter Psychiatric Institute, San Francisco, CA
 
3.24
Sensation Seeking As Risk Factor for Suicidal Ideation and Suicide Attempts in Adolescence
Ana Ortin, Ph.D. New York State Psychiatric Institute; Columbia University Medical Center, New York, NY
Marjorie Kleinman, M.S. New York State Psychiatric Institute; Columbia University Medical Center, New York, NY
Alison M. Lake, M.A. New York State Psychiatric Institute, New York, NY
Madelyn S. Gould, M.P.H., Ph.D. Columbia University; New York State Psychiatric Institute, New York, NY
 
3.25
Trends in Antipsychotic Prescriptions to Children and Adolescents in British Columbia, Canada: 1996 – 2010
Constadina Panagiotopoulos, M.D., FRCPC British Columbia Children's Hospital, Vancouver, BC
Dianna C. Louie, M.D. BC Children's Hospital, Vancouver, BC
William P. Warburton, Ph.D. Ministry of Health, Victoria, BC
Ramsay D. Hamdi, M.B.A. British Columbia Ministry of Health, Victoria, BC
David Scott, M.A. British Columbia Ministry of Health, Victoria, BC
Jana-Lea Davidson, M.D., FRCPC University of British Columbia, Vancouver, BC
 
3.26
Is the Rate of Adolescent Non-Suicidal Self-Injury Increasing?
Paul L. Plener, M.D. University of Ulm, Ulm Germany
Marthe Preiss University of Ulm, Ulm Germany
Nina Sproeber, Ph.D. University of Ulm, Ulm Germany
 
3.27
Prenatal Exposure to Binge Pattern Alcohol Consumption: Child Mental Health and Learning Outcomes at Age 11
Kapil S. Sayal, M.R.C.Psych., Ph.D. University of Nottingham, Nottingham United Kingdom
Jon Heron, Ph.D. University of Bristol, Bristol United Kingdom
Elizabeth S. Draper, Ph.D. University of Leicester, Leicester United Kingdom
Rosa Alati, Ph.D. University of Queensland, Brisbane Australia
Sarah J. Lewis, Ph.D. University of Bristol, Bristol United Kingdom
Robert B. Fraser, M.D. University of Sheffield, Sheffield United Kingdom
Margaret Barrow, M.D. University Hospitals of Leicester National Health Service Trust, Leicester United Kingdom
Jean Golding, Ph.D. University of Bristol, Bristol United Kingdom
Alan Emond, M.D. University of Bristol, Bristol United Kingdom
George Davey-Smith, M.D. University of Bristol, Bristol United Kingdom
Ron Gray, F.R.C.Psych. University of Oxford, Oxford United Kingdom
 
3.28
Health Risk Behaviors Over Time Among Youth with ADHD
Susanna Visser, M.S. Centers for Disease Control and Prevention, Atlanta, GA
Melissa Danielson, M.S. Centers for Disease Control and Prevention, Atlanta, GA
Steven P. Cuffe, M.D. University of Florida College of Medicine-Jacksonville, Jacksonville, FL
Robert E. McKeown, Ph.D. University of South Carolina, Columbia, SC
Rebecca H. Bitsko, Ph.D. Centers for Disease Control and Prevention, Atlanta, GA
Angelika Hartl Claussen, Ph.D. Centers for Disease Control and Prevention, Atlanta, GA
David E. Bard, Ph.D. University of Oklahoma Health Sciences Center, Oklahoma City, OK
Mark Wolraich, M.D. University of Oklahoma Health Sciences Center, Oklahoma City, OK
 
3.29
Substance Use Initiation in Adolescents At Risk for Depression
Douglas E. Williamson, Ph.D. University of Texas Health Science Center at San Antonio, San Antonio, TX
Rene Luis Olvera, M.D., M.P.H. University of Texas Health Science Center at San Antonio, San Antonio, TX
 
3.32
A New Measure of Irritability for Adolescents
Khrista R. Boylan, M.D., Ph.D. McMaster University, Hamilton, ON
Leslie E. Born, Ph.D. McMaster University, Hamilton, ON
 
3.33
Psychopathology in Children with Non-Epileptic Seizures
Sigita Plioplys, M.D. Children's Memorial Hospital and Feinberg School of Medicine, Northwestern University, Chicago, IL
Julia Doss, Psy.D. Minnesota Epilepsy Group, St. Paul USA
Prabha Siddarth, Ph.D. Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles, Los Angeles, CA
Brenda Bursch, Ph.D. David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA
Tatiana Falcone, M.D. Cleveland Clinic, Cleveland, OH
Marcy Forgey, M.D., M.P.H. UCLA Division of Child and Adolescent Psychiatry, Los Angeles, CA
Kyle Hinman, M.D. Lucile Packard Children's Hospital at Stanford, Stanford, CA
Richard J. Shaw, M.D. Stanford University, Palo Alto, CA
Deborah M. Weisbrot, M.D. Stony Brook University Medical Center, Stony Brook, NY
Rochelle Caplan, M.D. Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles, Los Angeles, CA
 
3.34
Convergent Validity of the Autism Mental Status Examination Using the ADOS Severity Metric
David Grodberg, M.D. Mount Sinai School of Medicine, New York, NY
Paige M. Weinger, M.A. Mount Sinai School of Medicine; Ferkauf Graduate School of Psychology, Yeshiva University, New York, NY
Latha Soorya, Ph.D. Mount Sinai School of Medicine, New York, NY
Alexander Kolevzon, M.D. Mount Sinai School of Medicine, Seaver Autism Center, New York, NY
Joseph D. Buxbaum, Ph.D. Mount Sinai Medical Center, New York, NY
 
3.35
The Overlapping and Distinct Presentations of ADHD and Autism Spectrum Disorder: An Examination of the Autism Spectrum Continuum
Rebecca Grzadzinski, B.A. New York University Child Study Center, Institute for Pediatric Neuroscience, NY, NY
Rebecca Lange, B.A. New York University Child Study Center, Institute for Pediatric Neuroscience, New York, NY
Jennifer Rodman, Ph.D. New York University Child Study Center, Institute for Pediatric Neuroscience, New York, NY
Elizabeth Roberts, Psy.D. New York University Child Study Center, New York, NY
Eva Petkova, Ph.D. New York University Child Study Center, Institute for Pediatric Neuroscience, New York, NY
Catherine Lord, Ph.D. Weill Cornell Medical College; New York Presbyterian Hospital, New York, NY
F. Xavier Castellanos, M.D. New York University Langone Medical Center, New York, NY
Adriana Di Martino, M.D. New York University Langone Medical Center, New York, NY
 
3.36
Child Brain Development Measured Using Electroencephalogram
Halla Helgadottir, M.S. Mentis Cura, Reykjavík Iceland
Kristinn Johnsen, Ph.D. Mentis cura, Reykjavík Iceland
Gisli Baldursson, M.D. Landspítali Hospital, Reykjavik Iceland
Berglind Brynjólfsdóttir, M.A. Child and Adolescent Psychiatry University Hospital in Iceland, Reykjavík Iceland
Gudrun Bryndís Gudmundsdottir, M.D. Landspitali University Hospital, Reykjavik Iceland
Nicolas Blin, M.S. Mentis Cura, Reykjavík Iceland
Asdis Emilsdottir, R.N. Mentis cura, Reykjavík Iceland
Gisli Johannesson, Ph.D. Mentis Cura, Reykjavík Iceland
Paula Kay Newman, M.A. Mentis Cura, Reykjavík Iceland
Pall Magnusson, M.S. Landspitali University Hospital, Reykjavik Iceland
Olafur O. Gudmundsson, M.D. Landspítali Hospital, Reykjavik Iceland
 
3.37
Cross-Informant Agreement on Child and Adolescent Withdrawn Behavior: A Latent Class Approach
David H. Rubin, M.D. Weill Cornell Medical College, New York USA
Robert Althoff, M.D., Ph.D. University of Vermont, Burlington, VT
John T. Walkup, M.D. Weill Cornell Medical College, New York, NY
James J. Hudziak, M.D. Vermont Center For Children, Youth, and Families, Burlington, VT
 
3.38
Cognitive Profile of Indian Children with Global Developmental Delay
Manjit Sidhu, Ph.D. CHILDLINE, Chandigarh India
Prahbhjot Malhi, Ph.D. Professor, Chandigarh India
Jagat Jerath Professor (Retd.), Panjab University, Chandigarh India
 
3.39
The Effectiveness of School-Based Mental Health Literacy Programs to Enhance Knowledge, Change Attitudes, and Improve Help-Seeking Behaviors Among Youth (Age 12 to 25): Systematic Review and Meta-Analysis
Yifeng Wei Sr., M.A. Izaak Walton Killam Health Centre, Dalhousie University, Halifax, NS
Austin Zygmunt Jr., B.S. Dalhousie University, Halifax, NS
Jill A. Hayden, Ph.D. Dalhousie University, Halifax, NS
Stan Kutcher, M.D. Dalhousie University, Izaak Walton Killam Health Centre, Halifax, NS
Patrick McGrath, Ph.D. Dalhousie University, Halifax, NS
 
3.40
12 Months Follow-up of Zarima Intervention (A Spanish Eating Disorder Prevention Program)
Pedro Manuel Ruiz-Lázaro Sr., M.D., Ph.D. Hospital Clínico Universitario de Zaragoza; Instituto Aragonés de Ciencias de la Salud I+CS, Zaragoza Spain
José Andrés Gómez Sr., M.D. Hospital Universitario Marqués de Valdecilla de Santander, Santander Spain
Jesús Pérez Sr., Ph.D. Hospital de Conxo de Santiago de Compostela, Santiago de Compostela Spain
María Calado Sr., Ph.D. Hospital Meixoeiro de Vigo, Vigo Spain
Maite Aranzazu Zapata Sr., M.D. Hospital Clínico Universitario de Zaragoza, Zaragoza Spain
Ana Isabel Calvo Sr., M.D. Hospital Clínico Universitario de Zaragoza, Zaragoza Spain
Antonio Lobo Sr., M.D. Hospital Clínico Universitario de Zaragoza, Zaragoza Spain
Jose Mariano Velilla Sr., M.D. Hospital Clínico Universitario de Zaragoza, Zaragoza Spain
 
3.41
Participation in Adult-Child Mentoring: A Canadian Perspective on the Big Brothers Big Sisters Program
Ellen Lipman, M.D. McMaster University, Hamilton, ON
David Dewit, Ph.D. Centre for Addiction and Mental Health, London, ON
 
3.42
Propranolol, a Possible Treatment to Prevent Post Traumatic Stress Disorder
Walter John Meyer III, M.D. University of Texas Medical Branch at Galveston, Galveston, TX
Laura E. Rosenberg, Ph.D. Shriners Hospitals for Children, Galveston, TX
Marta Rosenberg, Ph.D. Shriners Hospitals for Children, Galveston, TX
Helen Fuchs, B.A. Shriners Hospitals for Children, Galveston, TX
Charles E. Holzer III, Ph.D. University of Texas Medical Branch at Galveston, Galveston, TX
Celeste C. Finnerty, Ph.D. University of Texas Medical Branch at Galveston, Galveston, TX
David Herndon, M.D. University of Texas Medical Branch at Galveston, Galveston, TX
 
3.43
A Cross-Cultural Comparison of Clinically Referred Children and Adolescents with Tourette's Disorder
Barbara J. Coffey, M.D., M.S. New York University Child Study Center, New York, NY
María Beatriz Moyano, M.D. Favaloro University, Buenos Aires Argentina
Stephanie Samar, M.A. New York University Child Study Center, New York, NY
Marta Brana-Berrios, M.D. New York University Child Study Center, New York, NY
Amanda Lauren Zwilling, B.A. New York University Child Study Center, New York, NY
Gustavo Irazoqui Centro Interdisciplinario de Tourette, TOC y Trastornos Asociados, Buenos Aires Argentina
Rafael Kichic Institute of Cognitive Neurology (INECO), Buenos Aires Argentina
Angeles Matos Centro Interdisciplinario de Tourette, TOC y Trastornos Asociados, Buenos Aires Argentina
Mirta Romalde, M.D. Favaloro University, Buenos Aires Argentina
Analia Espino, M.D. Centro Interdisciplinario de Tourette, TOC y Trastornos Asociados, Buenos Aires Argentina
 
3.44
A Dimensional Study of Anxiety and Tic Severity in Children and Adolescents with Tourette's Disorder
Barbara J. Coffey, M.D., M.S. New York University Child Study Center, New York, NY
Vilma Gabbay, M.D., M.S. New York University School of Medicine, New York, NY
Amanda Lauren Zwilling, B.A. New York University Child Study Center, New York, NY
Stephanie Samar, M.A. New York University Child Study Center, New York, NY
Sarah Matson, B.S. New York University Child Study Center, New York, NY
 
3.45
Utility of the Diagnostic Interview Schedule for Children (DISC) for Assessing Tic Disorder in Children
Tanya K. Murphy, M.D., M.S. University of South Florida, Saint Petersburg, FL
Adam B. Lewin, A.B.P.P., Ph.D. University of South Florida, Saint Petersburg, FL
Jonathan W. Mink, M.D., Ph.D. University of Rochester, Rochester, NY
Rebecca H. Bitsko, Ph.D. Centers for Disease Control and Prevention, Atlanta, GA
Eric A. Storch, Ph.D. University of South Florida, St. Petersburg, FL
Leah Jung, B.A. University of South Florida, Saint Petersburg, FL
Erika F. Augustine, M.D. University of Rochester Medical Center, Rochester, NY
Heather R. Adams, Ph.D. University of Rochester, Rochester, NY
Lawrence Scahill, M.S.N., Ph.D. Yale Child Study Center, New Haven, CT
Amy E. Vierhile, M.S. University of Rochester Medical Center, Rochester, NY
 
3.46
The Prevalence of Tic Disorders: A Systematic Review and Meta-Analysis
Tristan E. Knight Royal College of Surgeons in Ireland, Dublin Ireland
Thomas D. Steeves, M.D. University of Toronto, Toronto, ON
Lundy J. Day, B.S. University of Calgary, Calgary, AB
Nathalie Jette, M.D., FRCP, M.S.C. University of Calgary, Calgary, AB
Tamara Pringsheim, M.D. Calgary Tourette and Pediatric Movement Disorder Clinic, Calgary, AB
 
3.47
Treatment Outcomes for Comorbid Tourette's Disorder and Associated Disorders in a Specialized Outpatient Tertiary Clinic
Colin King, M.A. Child and Parent Resource Institute, London, ON
Laura A. Theall-Honey, M.S. Child and Parent Resource Institute, London, ON
Shannon L. Stewart, Ph.D. Child and Parent Resource Institute, London, ON
B. Duncan McKinlay, Ph.D. Child and Parent Resource Institute, London, ON
 
3.48
Indicators of School Functioning Among Children with Tourette Syndrome: National Survey of Children's Health
Rebecca H. Bitsko, Ph.D. Centers for Disease Control and Prevention, Atlanta, GA
Angelika Hartl Claussen, Ph.D. Centers for Disease Control and Prevention, Atlanta, GA
Jeannette Bloomfield, M.S. Centers for Disease Control and Prevention, Atlanta, GA
Susanna Visser, M.S. Centers for Disease Control and Prevention, Atlanta, GA
Kathy Giordano, B.S. Tourette Syndrome Association, Inc, Bayside, NY
 
3.49
Sensory Phenomena Associated with Tics and Obsessive Compulsive Symptoms in Patients with Tourette's Disorder
Yukiko Kano, M.D., Ph.D. The University of Tokyo, Graduate School of Education, Tokyo Japan
Natsumi Kikuchi, M.A. The University of Tokyo, Graduate School of Education, Tokyo Japan
Toshiaki Kono, Ph.D. National Institute of Mental Health, Tokyo Japan
Maiko Nonaka, M.A. The University of Tokyo, Graduate School of Education, Tokyo Japan
Hitoshi Kuwabara, M.D., Ph.D. The University of Tokyo, Graduate School of Education, Tokyo Japan
Takafumi Shimada, M.D. The University of Tokyo, Graduate School of Education, Tokyo Japan
 
3.53
Childhood Dysregulation Is Associated with Brain-Derived Neurotrophic Factor and the Serotonin 2A Receptor
Rachel K. McEntee, B.A. University of Vermont College of Medicine, Burlington, VT
Robert Althoff, M.D., Ph.D. University of Vermont, Burlington, VT
Erik A. Ehli, M.S., R.N. Avera Institute for Human Behavioral Genetics, Sioux Falls, SD
Gareth E. Davies, Ph.D. Avera Institute for Human Behavioral Genetics, Sioux Falls, SD
James J. Hudziak, M.D. Vermont Center For Children, Youth, and Families, Burlington, VT
 
3.54
The Role of Oxytocin and Oxytocin Receptor Gene Variants in Childhood-Onset Aggression
Ayesha I. Malik, B.S. Centre for Addiction and Mental Health, Toronto, ON
Clement Zai, Ph.D. Centre for Addiction and Mental Health, Toronto, ON
Joseph H. Beitchman, M.D. Centre of Addiction and Mental Health and University of Toronto, Toronto, ON
 
3.55
Interaction of Dopaminergic and Noradrenergic Gene Polymorphisms on Methylphenidate Response in a Korean ADHD Sample
Soon-Beom Hong, M.D. Seoul National University College of Medicine, Seoul South Korea
Jae-Won Kim, M.D., Ph.D. Seoul National University Hospital, Seoul South Korea
Soo-Churl Cho, M.D., Ph.D. Seoul National University College of Medicine, Seoul South Korea
Min-Sup Shin, Ph.D. Seoul National University College of Medicine, Seoul South Korea
Bung-Nyun Kim, M.D., Ph.D. Seoul National University College of Medicine, Seoul South Korea
Hee-Jeong Yoo, M.D., Ph.D. Seoul National University College of Medicine, Seoul South Korea
 
3.56
A Zebrafish Model for the Functional Analysis of Genes in Autism
Ellen J. Hoffman, M.D. Yale School of Medicine, New Haven, CT
Antonio Giraldez, Ph.D. Yale School of Medicine, New Haven, CT
Matthew W. State, M.D., Ph.D. Yale Child Study Center, New Haven, CT
 
3.57
Pharmacogenomic Predictors of Risperidone Treatment Response in Autism-Related Irritability and Social Withdrawal
Erika L. Nurmi, M.D., Ph.D. University of California, Los Angeles, Los Angeles, CA
Samantha L. Spilman University of California, Los Angeles, Los Angeles, CA
Ksenya K. Badashova, B.S. University of California, Los Angeles, Los Angeles, CA
James T. McCracken, M.D. Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles, Los Angeles, CA
RUPP Autism Network , NA, AL
 
3.58
Gender-Specific Genetic-Based Approach Improves Identification of Siblings At Risk of Autism in Multiplex Families
Claire Amiet, M.D. Integragen, Evry France
David Cohen, M.D., Ph.D. APHP, GH Pitié-Salpétrière, UPMC, Paris France
Elizabeth Couchon, M.S. Integragen, Cambridge, MA
François Liebaert, M.D., M.B.A. Integragen, Evry France
Jerôme Carayol, Ph.D. Integragen, Evry France
Thomas Rio Frio, Ph.D. Integragen, Evry France
 
3.59
Relationship Between MDR1 C.2677G>T Variation and Adverse Drug Reactions of OROS-Methylphenidate in Korean Children and Adolescents with ADHD
Ki-Hwan Yook, M.D. CHA University, Gyeonggido South Korea
So Won Kim, M.D. Yonsei University College of Medicine, Seoul South Korea
Ji Hyun Lee, Ph.D. Yonsei University College of Medicine, Seoul South Korea
Min A. Song, M.D. Hallym University Sacred Heart Hospital, Kyeonggi-do South Korea
Hyun Ju Hong, M.D. Hallym University Sacred Heart Hospital, Anyang Kyunggi-do South Korea
 
3.60
Rare Copy Number Variants in Tourette's Disorder Disrupt Genes in Histaminergic Pathways and Overlap with Autism
Thomas V. Fernandez, M.D. Yale Child Study Center, New Haven, CT
Stephan Sanders, M.D. Yale University, New Haven, CT
A. Gulhan Ercan-Sencicek, Ph.D. Yale Child Study Center, New Haven, CT
Youeun Song, M.D. Yale School of Medicine, New Haven, CT
James F. Leckman, M.D. Yale Child Study Center, New Haven, CT
Robert A. King, M.D. Yale Child Study Center, New Haven, CT
Donald L. Gilbert, M.D. University of Cincinnati College of Medicine, Cincinnati, OH
Gary A. Heiman, Ph.D. Rutgers University, Piscataway, NJ
Jay A. Tischfield, Ph.D. Rutgers University, Piscataway, NJ
Pieter J. Hoekstra, M.D., Ph.D. University Medical Center Groningen, University of Groningen, Groningen Netherlands
Matthew W. State, M.D., Ph.D. Yale Child Study Center, New Haven, CT
See more of: New Research Poster